Reply to "Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era"

Affiliations

• ¹ Faculty of Medicine, University of Zurich, Zurich, Switzerland; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
• ² Faculty of Medicine, University of Zurich, Zurich, Switzerland; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland; Christine Kühne Center for Allergy Research and Education CK-CARE, Davos, Switzerland.
• ³ Department of Dermatology, University of California, Davis, Sacramento, Calif.
• ⁴ Faculty of Medicine, University of Zurich, Zurich, Switzerland; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland; Christine Kühne Center for Allergy Research and Education CK-CARE, Davos, Switzerland. Electronic address: [email protected].